Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Company (HBB) Market Cap

Hamilton Beach Brands Holding Company has a market capitalization of $271.2M.

Financials based on reported quarter end 2025-12-31

Price: $20.20

โ–ผ -0.11 (-0.54%)

Market Cap: 271.20M

NYSE ยท time unavailable

CEO: R. Scott Tidey

Sector: Consumer Cyclical

Industry: Furnishings, Fixtures & Appliances

IPO Date: 2017-09-26

Website: https://www.hamiltonbeachbrands.com

Hamilton Beach Brands Holding Company (HBB) - Company Information

Market Cap: 271.20M ยท Sector: Consumer Cyclical

Hamilton Beach Brands Holding Company, together with its subsidiaries, designs, markets, and distributes small electric household and specialty housewares appliances in the United States and internationally. It offers air fryers, blenders, food processors, coffee makers, indoor electric grills, irons, juicers, mixers, slow cookers, toasters, and toaster ovens. The company also provides air purifiers under the TrueAir brand; consumer products under the Hamilton Beach and Proctor Silex brands; commercial products for restaurants, fast food chains, bars, and hotels under the Hamilton Beach Commercial and Proctor Silex Commercial brands; and personal care products under the Brightline brand, as well as products under the Hamilton Beach Professional in the premium market. In addition, it offers countertop appliances under the Wolf Gourmet brand; garment care products under CHI brand; farm-to-table and field-to-table food processing equipment under the Weston brand; cocktail delivery system under the Bartesian brand; and supplies private label products. The company sells its products through a network of mass merchandisers, e-commerce retailers, national department stores, variety store and drug store chains, specialty home retailers, distributors, restaurants, bars, hotels, and other retail outlets. Hamilton Beach Brands Holding Company was founded in 1904 and is headquartered in Glen Allen, Virginia.

Analyst Sentiment

50%
Hold

Based on 1 ratings

Consensus Price Target

No data available

Price & Moving Averages

Loading chart...

Fundamentals Overview

Loading fundamentals overview...

HBB delivered a sharp recovery in Q4 2025 despite flat revenue, with margins and profitability meaningfully improved. Gross margin expanded 220 bps YoY to 28.3% (and >700 bps vs Q3) on pricing timing, mix shift toward commercial/health, and labor/logistics efficiencies. Operating profit rose 8% and operating margin improved 90 bps to 11.9%, even as SG&A increased for performance comp catch-up, incremental advertising, and $1.6M legacy ERP accelerated depreciation/write-off. The company framed 2025 as tariff-disrupted but manageable: full-year revenue down 7.3% and gross margins down only 30 bps, with onetime tariffs and ERP transition explaining much of the reported operating profit gap. For 2026, management expects mid-single-digit revenue growth weighted to Q2/Q3 and gross margins similar to slightly better than 2025, but operating profit is expected to decline low-teens % due to ~$6M ERP accelerated depreciation and ~$6M planned advertising. Key growth engines are Lotus premium expansion (incremental, double-digit sell-through), commercial penetration via Summit Edge and Sunkist commercial juicers, and HealthBeacon scale-up (Synerwell/Lumicera, Novartis Harmony, +50% subscriptions).

AI IconGrowth Catalysts

  • Lotus premium brand: initial sell-through in Q4 exceeded expectations by strong double digits; Lotus Signature scheduled launch this fall 2026
  • Commercial division: Summit Edge blender advanced blending/mixing technologies driving over 15% commercial growth for full year
  • Commercial pipeline: multiple automated beverage products for restaurant/hospitality chain menu items (partner rollouts)
  • Health division profitability turnaround: HealthBeacon positive operating profit in Q3 2025 (~18 months post-acquisition) and again in Q4 2025
  • Health expansion: expanding specialty pharmacy partnerships with Synerwell and Lumicera; HealthBeacon Harmony software products launched with Novartis
  • HealthBeacon subscriber growth: patient subscription base increased by 50% in 2025
  • 2026 product launches: 3 new blender systems; Durathon Iron redesign; new Durathon and CHI garment steamers; 2 new single-serve coffee platforms
  • 2026 digital growth: increased advertising investment to more than the past 4 years combined; AI shopping tactics and improved discoverability
  • Health platform trials: Q2 2026 trial for pill management platform (adherence + patient feedback); focus areas oncologic and mental health

Business Development

  • Sunkist: agreement to develop and market Sunkist branded commercial juicers and sectionizers (launched in Q2; demand from leading restaurants, hospitality chains, and schools accelerated)
  • Specialty pharmacy partnerships: Synerwell and Lumicera
  • Novartis: launched HealthBeacon Harmony software products with Novartis
  • Automated beverage products: partnering with several large chains to launch multiple automated beverage products for new menu items
  • Bartesian: licensing agreement expiration at end of 2025 creating a ~$22 million sales headwind in 2026

AI IconFinancial Highlights

  • Q4 revenue $212.9M vs $213.5M prior year (down 30 bps YoY; nearly flat)
  • Q4 gross margin 28.3% vs 26.1% prior year: +220 bps YoY; also described as >700 bps higher than Q3
  • Q4 operating profit +8% to $25.4M vs $23.6M; operating margin +90 bps to 11.9%
  • Q4 SG&A $34.7M vs $32.1M: includes +$1.5M additional advertising spend and +$1.6M accelerated depreciation/write-off from legacy ERP system; also higher performance-based compensation accrual
  • Q4 net interest expense $0.43M vs $0.283M prior year due to higher debt levels (partly offset by lower rates)
  • Q4 income tax expense $6.5M vs $1.0M benefit prior year (tax change primarily due to $4.3M foreign tax benefit and a U.S. tax accounting method change benefiting the prior year)
  • Q4 net income $18.5M / $1.38 diluted EPS vs $24.0M / $1.75 diluted EPS prior year
  • Full-year 2025 revenue $606.9M (down 7.3% from $654.7M)
  • Full-year gross margin 25.7% (down 30 bps) despite $5.3M one-time incremental tariffs
  • Full-year operating profit: reported $36.6M (6.0% of sales) vs $43.2M (6.6%) prior year; excluding $5.3M incremental tariffs and accelerated depreciation/write-off for legacy ERP, operating profit increased to $43.5M (7.2% of sales)
  • Full-year net income $26.5M / $1.95 EPS vs $30.8M / $2.20 EPS prior year; effective tax rate 25.8% (2025) vs 7.8% (2024)

AI IconCapital Funding

  • 2025 shareholder returns: repurchased ~507,000 shares for ~$9M and paid $6.4M dividends
  • Net debt end of 2025: $2.7M vs net cash $0.6M at Dec 31, 2024
  • 2026 cash flow from operations less investing expected $35M to $45M (benefiting from normalization of tariff-related net working capital impacts)

AI IconStrategy & Ops

  • Manufacturing diversification away from China; tariff parity flexibility across APAC sourcing countries (China vs Vietnam/Thailand/Indonesia) to shift production based on economic/tariff conditions
  • Pricing strategy implementation and inventory/proactive inventory management contributing to Q4 recovery
  • Advertising strategy: incremental investment and digital transformation; more than past 4 years combined advertising spend in 2026; enhanced AI shopping tactics and social/influencer marketing; multiple platform presence/discoverability
  • ERP modernization: upgrading ERP platform causing accelerated depreciation on existing system; described as intentional to unlock benefits from emerging technologies post-migration
  • 2025 cost actions: restructuring actions taken during Q2

AI IconMarket Outlook

  • 2026 revenue growth expected to approach mid-single-digit range; weighted toward Q2 and Q3
  • 2026 gross margins expected similar to slightly better than 2025
  • 2026 operating profit (reported basis) expected to decline low teens on a percentage basis inclusive of ~$6M accelerated depreciation (legacy ERP) and ~$6M planned advertising spend (particularly 2H 2026)
  • 2026 sales headwind: ~$22M from Bartesian license expiration at end of 2025
  • Q2 2026 trial planned for pill management platform

AI IconRisks & Headwinds

  • Tariff uncertainty: uncertainty around future tariff rates; 2025 disruption included retailer suspensions of purchasing for ~6 weeks in April-May
  • U.S. consumer volume pressure vs commercial/health offsets: Q4 consumer volumes lower YoY; full-year decline attributed to lower volumes in U.S. consumer as retailers adjusted buying
  • One-time and nonrecurring impacts in comparables: $5.3M incremental tariffs and accelerated depreciation/write-off tied to legacy ERP system
  • 2026 headwind from Bartesian licensing expiration (~$22M sales reduction)
  • Working capital variability: 2025 operating cash flow decreased primarily due to increase in net working capital (including lower accounts payable as inventory builds were anniversaryed)

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HBB Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
๐Ÿ“

SEC Filings (HBB)

ยฉ 2026 Stock Market Info โ€” Hamilton Beach Brands Holding Company (HBB) Financial Profile